Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital
-
Equip Exposition Announces $5000 Summer Shopping Spree Sweepstakes
-
Full Alliance Group's Pure Solutions Announces Manufacturing Agreement With Stemtech Corporation for New StemPets(TM) Product Line
-
Breastfeeding Is Linked to Significant Long-Term Benefits. PRENALACT® Can Help
-
Clever Builds Featured in Rock the Block Season 6 Finale on HGTV
-
Sitka Intercepts Multiple Occurrences of Visible Gold in First Drill Holes of the Summer Season at Its RC Gold Project, Yukon
-
Sonim Technologies Signs Letter of Intent to Sell Substantially All Assets to Social Mobile
-
Adequate own funds and the internal capital adequacy requirement - Danish Ship Finance A/S
-
BTCS Inc. Utilizes Crypto.com and Acquires 1,000 ETH, Expanding Ethereum Holdings to 13,500 ETH
-
Sébastien Jacquet Appointed Chief Quality Officer
-
Get ready for a new wave of clinical trials in Schizophrenia: how Sites and Sponsors can avoid conceptual mistakes, Upcoming Webinar Hosted by Xtalks
-
Driving Agility in Drug Discovery: Integrating Predicted and Empirical Data, Upcoming Webinar Hosted by Xtalks
-
Strategies for Sustainable Purification of Peptides Using Flash Chromatography, Upcoming Webinar Hosted by Xtalks
-
BENEO (June 12/25) Faba Beans: Solutions in Baked Goods and Dairy-Free Applications, Upcoming Webinar Hosted by Xtalks
-
First-Ever Blueberry Boost Accelerator Seeks Next Generation of Food and Consumer Product Innovation
-
Cactus Club Cafe Announces Expansion to South Florida
-
Concurrent Expands Partnership with TIFIN to Empower Advisors and Drive Better Investor Outcomes
-
Berkshire Biomedical Awarded NIH Research Grant to Support Clinical Study Program to Evaluate Patient Retention and Other Benefits of the COPA™ System for Take-Home Methadone Medication Management
-
Consolidated Water Increases Dividend and Declares Third Quarter Cash Dividend of $0.14 per Share
-
FDA expands XENOVIEW® indication to include children from six years of age
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares
-
PayToMe.co Accepted into NVIDIA Inception Program, Joining Elite 1% of Global AI Startups
-
New York Mortgage Trust, Inc. Announces Consent Solicitation Related to Senior Notes due 2026 to Support Strategic Growth
-
Clarivate Completes Refinancing of Majority of Senior Secured Notes Due 2026
-
Arrive in Elegance With Professional Limousine Services You Can Trust
-
Where to Buy Laminated Glass A Short Guide
-
Nukkleus to Present at Two Upcoming Investor Conferences
-
Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update
-
LUXE Bidet Named Finalist for Buyers' Choice Award at ECRM Expo 2025
-
iRocket and Wilbur Ross-Backed BPGC Acquisition Corp. Announce a $400 Million Merger Letter of Intent for a Business Combination to Transform the Space Launch Industry and List iRocket on Nasdaq
-
Taoping Selected for New US$2.8 Million Agricultural Product Supply Contract; Company Continues to Build Momentum in Important Growth Market
-
Safe & Green Holdings Corp. Signs Letter of Intent to Acquire Giant Containers Inc.
-
Oxford Cancer Biomarkers partners with Mira Precision Health to advance its ToxNav® test for predicting patient toxicity to 5FU/capecitabine treatment in the USA
-
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.32 per Common Share for 2Q25
-
Neurocrine Biosciences Presents Patient-Reported Outcomes from KINECT-PRO™ Study Demonstrating INGREZZA® (valbenazine) Capsules Improved Functionality and Quality of Life in Patients with Tardive D
-
ICE launches battery raw materials futures contracts based on Fastmarkets price assessments
-
LogicMark, Inc. Common Stock to Commence Trading on OTC Markets as the Company Continues Advancing Growth Initiatives
-
SalamAir Enhances Global Distribution Strategy through Sabre Partnership
-
Syncromune® Inc. Presents Positive Results from SYNC-T® Therapy SV-102 Phase 1 Metastatic Prostate Cancer Trial at ASCO 2025
-
The Luminos Fund secures increased commitment of $10 million from founder Legatum to expand access to foundational learning for out-of-school children
-
SUBSCRIBE Launches SUBSCRIBE Altscape® Marketplace Connecting Alternative Asset Managers and Wealth Management Firms
-
SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025
-
Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
-
Arch MI Integration with Wilqo Brings Seamless Customer Experience
-
Elinzanetant Significantly Reduces Frequency of Moderate to Severe Vasomotor Symptoms Associated With Endocrine Therapy for Breast Cancer in Phase III Oasis-4 Study
-
Promethean balances intuitive tech and unique company culture with the ideal workplace solution
-
Manhattan Recognizes its Valued Partners at Momentum 2025
-
Galloway Capital Partners Announces 4.31% Stake in Babcock & Wilcox Enterprises, Inc.
-
Archer Showcases Piloted Midnight Flight As It Advances To Next Phase Of Flight Test Program
-
Amprius Sets June 2025 Events Schedule
